However, no research exists to show what benefits administering a sermorelin-ipamorelin blend may offer or whether, as these two peptides work along different pathways, a blend increases GH secretion more effectively
The orforglipron 45 mg oral daily dose conferred weight change from baseline of 12.6% at 26 weeks and 14.7% at 36 weeks
It won't match a prescription GLP-1 drug, but it's a legitimate way to lean on the same hormone system
Manufacturing scale and qualification pathways are well established (cell traceability, lot control, aging processes, QC routines)
My goal is to get inside your skin cells [and stay there] where the benefits are going to be. As the market expands, proprietary peptides and precision application will be the next frontier, according to Dr